Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 21 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BioSig Technologies Inc | BSGM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.33 | 03:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.33 |
| Trades | Shares Traded | Average Volume |
|---|---|---|
| 2 | 21 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 05:22:57 | 1 | US$ 1.33 | USD |
BioSig Technologies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 12.42M | 9.33M | - | 18k | -29.05M | -3.11 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioSig Technologies News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/07/2024 | 12:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/07/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/03/2024 | 11:22 | GlobeNewswire Inc. | BioSig Technologies, Inc. Announces New Appointments to its.. |
| 4/30/2024 | 13:03 | GlobeNewswire Inc. | BioSig Technologies, Inc. Appoints Mr. Anthony Amato to.. |
| 4/04/2024 | 10:35 | GlobeNewswire Inc. | BioSig Engages Consulting Firm for Business Model Strategies |
| 3/11/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/04/2024 | 19:04 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/28/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/20/2024 | 09:00 | GlobeNewswire Inc. | BioSig Announces Reduction of its Workforce |
| 2/14/2024 | 14:31 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 2/06/2024 | 07:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/06/2024 | 07:30 | GlobeNewswire Inc. | BioSig’s PURE EP™ Platform with New Near Field Tracking.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BSGM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
BioSig Technologies Description
| BioSig Technologiesis an advanced medical technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), BioSig is committed to addressing healthcare¿s biggest priorities-saving time, saving costs, and saving lives. The Company¿s first product, the PURE EP¿ System, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time signal visualization allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The global EP market is projected to reach $16B in 2028 with an 11.2% growth rate. |
